Suppr超能文献

中心性浆液性脉络膜视网膜病变半剂量光动力治疗后,脉络膜新生血管从病灶性脉络膜凹陷处直接出现:一例报告

Choroidal neovascularization emerged right from the focal choroidal excavation in eyes with central serous chorioretinopathy post half-dose photodynamic therapy: a case report.

作者信息

Liu Yang, Wang Xin, Zhu Min, Xu Gezhi, Li Lei

机构信息

Department of Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, 200032, China.

Shanghai Key Laboratory of Visual Impairment and Restoration, Eye and ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, 200032, China.

出版信息

BMC Ophthalmol. 2019 Mar 8;19(1):68. doi: 10.1186/s12886-019-1081-6.

Abstract

BACKGROUND

Focal choroidal excavation (FCE) is a common concurrent disease with central serous chorioretinopathy (CSC) and choroidal neovascularization (CNV). Photodynamic therapy (PDT) was able to cease the course of CSC with efficacy and safety. To retrospectively observed and followed up a special course in eyes with CSC and concurrent FCE treated by a half-dose of PDT.

CASE PRESENTATION

In this case report analysis, two eyes with CSC and concurrent FCE treated with half-dose PDT, were followed up with monthly retinal fundus examinations. Best corrected visual acuity (BCVA) and ophthalmic fundus examination were examined, including fundus photos, optical coherence tomography (OCT) and angiography. In Case 1, a 46-year-old female has been diagnosed as CSC and concurrent FCE. The baseline BCVA was 10/20. After a half-dose of PDT, complete resolution of SRF was achieved at one-month with stable BCVA. At 3 months, the patient complained of obvious metamorphosis. Multimodal images confirmed the existence of CNV, derived from the FCE, inside the zone of PDT irradiation. The development of CNV stopped promptly 1 month post the injection of ranibizumab. In Case 2, a 39 year-old male was diagnosed as bilateral CSC. The BCVA was 8/20 (od), and 16/20 (os). The multimodal images showed classic CSC manifestation in left eye, but atypical manifestation in right eye with subtle SRF and FCE. Post half-dose treatment, the SRF in left eye completely resolved at three-months, and the BCVA improved to 24/20. However, a lesion of CNV grew in the FCE after 1 month in right eye, with decreased BCVA, 4/20. One month post-injection of ranibizumab, obvious regression was witnessed, with improved BCVA, 6/20. The CNV proceeded to be a scar 2 months after injection. The BCVA maintained at 8/20.

CONCLUSIONS

In this study, type II CNV was induced in two cases of CSC concurrent with FCE in 3 months post half-dose PDT. The CNV grew right from the FCE, inside the zone of PDT irradiation.

摘要

背景

局限性脉络膜缺损(FCE)是中心性浆液性脉络膜视网膜病变(CSC)和脉络膜新生血管(CNV)的常见并发疾病。光动力疗法(PDT)能够有效且安全地终止CSC病程。回顾性观察并随访接受半剂量PDT治疗的CSC合并FCE患者的特殊病程。

病例报告

在本病例报告分析中,对2例接受半剂量PDT治疗的CSC合并FCE患者进行了每月一次的视网膜眼底检查随访。检查了最佳矫正视力(BCVA)和眼底检查,包括眼底照片、光学相干断层扫描(OCT)和血管造影。病例1中,一名46岁女性被诊断为CSC合并FCE。基线BCVA为10/20。半剂量PDT治疗后,1个月时视网膜下液(SRF)完全消退,BCVA稳定。3个月时,患者主诉明显变形。多模态图像证实,在PDT照射区域内,源自FCE的CNV存在。注射雷珠单抗1个月后,CNV的发展迅速停止。病例2中,一名39岁男性被诊断为双侧CSC。BCVA为8/20(右眼)和16/20(左眼)。多模态图像显示左眼为典型CSC表现,右眼为非典型表现,伴有细微的SRF和FCE。半剂量治疗后,左眼的SRF在3个月时完全消退,BCVA提高到24/20。然而,右眼在1个月后FCE处出现CNV病变,BCVA下降至4/20。注射雷珠单抗1个月后,可见明显消退,BCVA改善至6/20。注射2个月后,CNV形成瘢痕。BCVA维持在8/20。

结论

在本研究中,2例CSC合并FCE患者在半剂量PDT治疗3个月后发生了II型CNV。CNV直接从FCE处生长,位于PDT照射区域内。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cae4/6408815/9194b4dbe28d/12886_2019_1081_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验